Daehwa Pharmaceutical

• Food Effect on Pharmacokinetics and Safety of DHP107 (Liporaxel®) FEEL Study

  Phase 1, Completed, 25 people, 19 Dec 2020

• Oral Paclitaxel Trial In Recurrent and Metastatic Breast Cancer As 1st Line Therapy

  Phase 2/3, Active, not recruiting, 549 people, 20 Oct 2017

• NCT03055741

  Phase 2, Completed, 180 people, 16 Feb 2017

• Phase 3 Study to Compare Efficacy and Safety of DHP107 vs. Taxol® in Patients With Metastatic or Recurrent Gastric Cancer

  Phase 3, Completed, 238 people, 25 Apr 2013

Sources: clinicaltrials.gov